RESUMO
Systemic lupus erythematosus (SLE) is marked by a Th cell-dependent B cell hyperresponsiveness, with frequent germinal center reactions and hypergammaglobulinemia. The specificity of Th cells in lupus remains unclear, but B cell Ids have been suggested. A hallmark is the presence of anti-dsDNA, mutated IgG autoantibodies with a preponderance of arginines in CDR3 of the Ig variable H chain (IgVH). B cells can present V region-derived Id peptides on their MHC class II molecules to Id-specific Th cells. We show that Id-specific Th cells support the proliferation of anti-dsDNA Id(+) B cells in mice suffering from systemic autoimmune disease with SLE-like features. Mice developed marked clonal expansions of B cells; half of the IgVH sequences were clonally related. Anti-dsDNA B cells made up 40% of B cells in end-stage disease. The B cells expressed mutated IgVH with multiple arginines in CDR3. Hence, Id-driven T cell-B cell collaboration supported the production of classical anti-dsDNA Abs, recapitulating the characteristics of such Abs in SLE. The results support the concept that Id-specific Th cells may trigger the development of SLE and suggest that manipulation of the Id-specific T cell repertoire could play a role in treatment.
Assuntos
Anticorpos Antinucleares/imunologia , Seleção Clonal Mediada por Antígeno/imunologia , DNA/imunologia , Lúpus Eritematoso Sistêmico/imunologia , Linfócitos T Auxiliares-Indutores/imunologia , Animais , Anticorpos Antinucleares/biossíntese , Arginina/química , Linfócitos B/imunologia , Sequência de Bases , Hipergamaglobulinemia/imunologia , Imunoglobulina G/imunologia , Cadeias Pesadas de Imunoglobulinas/genética , Cadeias Pesadas de Imunoglobulinas/imunologia , Idiótipos de Imunoglobulinas/genética , Idiótipos de Imunoglobulinas/imunologia , Região Variável de Imunoglobulina/genética , Ativação Linfocitária/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Transgênicos , Análise de Sequência de DNARESUMO
B cell lymphomas have been associated with chronic infections and autoimmunity. However, most lymphomas develop in the absence of any known chronic antigenic stimulation. B cells process their highly diversified endogenous immunoglobulin and present clonally unique variable-region idiotypic (Id) peptides on their major histocompatibility complex (MHC) class II molecules to Id-specific T cells. We show that B cells chronically helped by Id-specific Th2 cells developed into large B cell lymphomas with cytogenetic DNA aberrations. The lymphomas expressed high amounts of Id, MHC class II, CD80/86, and CD40 and bidirectionally collaborated with Th2 cells. Thus, MHC class II-presented Id peptides may represent a chronic self-antigenic stimulus for T cell-dependent lymphomagenesis. Eventually, B lymphomas grew independent of T cells. Thus, T cells do not only eliminate cancers as currently believed. In fact, Id-specific Th2 cells can induce B lymphomas.
Assuntos
Linfócitos B/imunologia , Linfoma Difuso de Grandes Células B/etiologia , Linfoma Difuso de Grandes Células B/imunologia , Subpopulações de Linfócitos T/imunologia , Células Th2/imunologia , Animais , Linfócitos B/metabolismo , Antígeno B7-1/metabolismo , Antígeno B7-2/metabolismo , Sequência de Bases , Antígenos CD40/metabolismo , Citometria de Fluxo , Genes de Cadeia Pesada de Imunoglobulina/genética , Antígenos de Histocompatibilidade Classe II/metabolismo , Idiótipos de Imunoglobulinas/metabolismo , Imuno-Histoquímica , Camundongos , Camundongos Transgênicos , Dados de Sequência Molecular , Análise de Sequência de DNARESUMO
To understand the biology of Ab-secreting cells in the human small intestine, we examined Ab production of intestinal biopsies kept in culture. We found sustained IgA and IgM secretion as well as viable IgA- or IgM-secreting cells after >4 wk of culture. The Ab-secreting cells were nonproliferating and expressing CD27 and CD138, thus having a typical plasma cell phenotype. Culturing of biopsies without tissue disruption gave the highest Ab production and plasma cell survival suggesting that the environment regulates plasma cell longevity. Cytokine profiling of the biopsy cultures demonstrated a sustained presence of IL-6 and APRIL. Blocking of the activity of endogenous APRIL and IL-6 with BCMA-Fc and anti-human IL-6 Ab demonstrated that both these factors were essential for plasma cell survival and Ab secretion in the biopsy cultures. This study demonstrates that the human small intestine harbors a population of nonproliferating plasma cells that are instructed by the microenvironment for prolonged survival and Ab secretion.
Assuntos
Imunidade nas Mucosas/imunologia , Imunoglobulina A/biossíntese , Imunoglobulina M/biossíntese , Plasmócitos/metabolismo , Biópsia , Separação Celular , Sobrevivência Celular , Duodeno/citologia , Duodeno/imunologia , Ensaio de Imunoadsorção Enzimática , Citometria de Fluxo , Humanos , Imunoglobulina A/imunologia , Imunoglobulina M/imunologia , Interleucina-6/imunologia , Interleucina-6/metabolismo , Mucosa Intestinal/imunologia , Mucosa Intestinal/metabolismo , Plasmócitos/imunologia , Técnicas de Cultura de Tecidos , Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral/imunologia , Membro 13 da Superfamília de Ligantes de Fatores de Necrose Tumoral/metabolismoRESUMO
Alloimmunization is a common phenomenon after transfusion, with an estimated incidence of 0.5% increasing to 20-60% in chronically transfused patients. In recently transfused patients, serological typing can be hampered by mixed field agglutination. We established RT-PCR methods for RHD, RHC/c and RHE/e typing using mRNA from reticulocytes. Molecular typing was performed soon after 51 separate mismatched transfusion events involving 30 patients. Accurate identification of the transfused patients' phenotype was confirmed in all cases. Reticulocyte maturation studies revealed that temperature is a crucial parameter for transition into mature red blood cells.
Assuntos
Tipagem e Reações Cruzadas Sanguíneas/métodos , RNA Mensageiro/sangue , Reticulócitos/química , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Isoimunização Rh/diagnóstico , Sistema do Grupo Sanguíneo Rh-Hr/genética , Reação Transfusional , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Artefatos , Proteínas de Transporte de Cátions/análise , Proteínas de Transporte de Cátions/genética , Sobrevivência Celular , Temperatura Baixa , DNA Complementar/genética , Transfusão de Eritrócitos , Eritropoese , Feminino , Testes de Hemaglutinação , Humanos , Procedimentos de Redução de Leucócitos , Masculino , Glicoproteínas de Membrana/análise , Glicoproteínas de Membrana/genética , Pessoa de Meia-Idade , Fenótipo , RNA Mensageiro/genética , Sistema do Grupo Sanguíneo Rh-Hr/análise , Fatores de TempoRESUMO
It has been suggested that VH4-34 gene segment expression is counter-selected in multiple myeloma (MM) due to a self-tolerance mechanism. We cloned and sequenced a VH4-34 gene segment from bone marrow mononuclear cells of a stage III MM patient. We show that VH4-34 was expressed by the serum IgA myeloma (M)-protein, as demonstrated by reactivity with the VH4-34 specific 9G4 mAb and mass spectrometry (MS). The M-protein had weak reactivity with nuclei. These results demonstrate that VH4-34 may be expressed in secreted IgA M-protein with weak autoreactivity. Thus, counter-selection of VH4-34 is pronounced but not absolute in MM. Mechanisms of how VH4-34 can occasionally be expressed in MM and clinical implications are discussed.
Assuntos
Imunoglobulina A/imunologia , Mieloma Múltiplo/imunologia , Proteínas do Mieloma/imunologia , Idoso , Sequência de Aminoácidos , Anticorpos Antinucleares/genética , Anticorpos Antinucleares/imunologia , Anticorpos Monoclonais/imunologia , Reações Antígeno-Anticorpo , Autoimunidade , Linfócitos B/imunologia , Linfócitos B/patologia , Sequência de Bases , Células Clonais/imunologia , Células Clonais/patologia , Análise Mutacional de DNA , Rearranjo Gênico de Cadeia Pesada de Linfócito B , Rearranjo Gênico de Cadeia Leve de Linfócito B , Genes de Imunoglobulinas , Humanos , Cadeias Pesadas de Imunoglobulinas/genética , Região Variável de Imunoglobulina/genética , Espectrometria de Massas , Dados de Sequência Molecular , Mieloma Múltiplo/patologia , Proteínas do Mieloma/genética , Células-Tronco Neoplásicas/imunologia , Células-Tronco Neoplásicas/patologia , Reação em Cadeia da Polimerase , Proteínas Recombinantes de Fusão/imunologia , Tolerância a Antígenos Próprios , Alinhamento de Sequência , Deleção de Sequência , Homologia de Sequência do Ácido NucleicoRESUMO
Systemic lupus erythematosus (SLE) is marked by a T helper (Th) cell-dependent B cell hyperresponsiveness, with frequent germinal center reactions, and gammaglobulinemia. A feature of SLE is the finding of IgG autoantibodies specific for dsDNA. The specificity of the Th cells that drive the expansion of anti-dsDNA B cells is unresolved. However, anti-microbial, anti-histone, and anti-idiotype Th cell responses have been hypothesized to play a role. It has been entirely unclear if these seemingly disparate Th cell responses and hypotheses could be related or unified. Here, we describe that H chain CDR3 idiotypes from IgG(+) B cells of lupus mice have sequence similarities with both microbial and self peptides. Matched sequences were more frequent within the mutated CDR3 repertoire and when sequences were derived from lupus mice with expanded anti-dsDNA B cells. Analyses of histone sequences showed that particular histone peptides were similar to VDJ junctions. Moreover, lupus mice had Th cell responses toward histone peptides similar to anti-dsDNA CDR3 sequences. The results suggest that Th cells in lupus may have multiple cross-reactive specificities linked to the IgVH CDR3 Id-peptide sequences as well as similar DNA-associated protein motifs.
RESUMO
There is increasing interest in the chronic lymphocytic leukemia (CLL) microenvironment and the mechanisms that may promote CLL cell survival and proliferation. A role for T helper (Th) cells has been suggested, but current evidence is only circumstantial. Here we show that CLL patients had memory Th cells that were specific for endogenous CLL antigens. These Th cells activated autologous CLL cell proliferation in vitro and in human â mouse xenograft experiments. Moreover, CLL cells were efficient antigen-presenting cells that could endocytose and process complex proteins through antigen uptake pathways, including the B cell receptor. Activation of CLL cells by Th cells was contact and CD40L dependent. The results suggest that CLL is driven by ongoing immune responses related to Th cell-CLL cell interaction. We propose that Th cells support malignant B cells and that they could be targeted in the treatment of CLL.
Assuntos
Leucemia Linfocítica Crônica de Células B/imunologia , Células Th1/imunologia , Animais , Células Apresentadoras de Antígenos/imunologia , Processos de Crescimento Celular/imunologia , Humanos , Leucemia Linfocítica Crônica de Células B/genética , Leucemia Linfocítica Crônica de Células B/patologia , Ativação Linfocitária , Camundongos , Camundongos Endogâmicos NOD , Camundongos SCID , Transcriptoma , Microambiente Tumoral/imunologiaRESUMO
BACKGROUND: The heavy-chain V4-34 germline gene segment is mandatory for pathologic cold-reacting autoantibodies with anti-I/i specificity (cold agglutinins) and is also preferentially used by monoclonal immunoglobulin M alloantibodies against D and other Rh antigens. The use of the V4-34 segment by monoclonal anti-D has previously been shown to also confer anti-I/i reactivity (cold agglutinin activity), which has implications for the use of such antibodies for Rh blood typing. V4-34 framework 1 (FR1) sequence is believed to be critical for cold agglutinin activity of cold agglutinins. STUDY DESIGN AND METHODS: The aim of this investigation was to use site-directed mutagenesis of a recombinant V4-34-encoded anti-D to determine the contribution of V4-34 FR1 sequence to anti-D activity and whether mutational modifications in the FR1 region could separately alter anti-D and anti-i activities. RESULTS: The results show that amino acid changes in V4-34 FR1 at W7, A23, and Y25 have a profound effect on anti-D activity as well as on anti-i activity. It was not possible to substantially reduce or remove anti-i activity without reducing anti-D activity to a comparable extent. CONCLUSIONS: The same nonpolar hydrophobic amino acids in FR1 are critical for maintaining both anti-D and anti-i activity. It is proposed that these residues influence the conformation of the antigen-binding site.
Assuntos
Anticorpos Monoclonais/genética , Anticorpos Monoclonais/imunologia , Sistema do Grupo Sanguíneo I/imunologia , Região Variável de Imunoglobulina/genética , Região Variável de Imunoglobulina/imunologia , Sistema do Grupo Sanguíneo Rh-Hr/imunologia , Animais , Especificidade de Anticorpos , Células CHO , Cricetinae , Cricetulus , Crioglobulinas/imunologia , Expressão Gênica/imunologia , Mutação em Linhagem Germinativa , Humanos , Hibridomas , Imunoglobulina M/genética , Imunoglobulina M/imunologia , Mutagênese Sítio-DirigidaRESUMO
Experiments in mice have suggested that engagement of receptors of innate immunity has an adjuvant effect on adaptive immune responses. Such studies need to be extended to humans. We have here constructed recombinant scFv-based vaccine candidate proteins (vaccibodies) that target human TLR2 and CD14 for delivery of large antigens. Vaccibodies are homodimers, each chain consisting of scFv specific for surface molecules on antigen-presenting cells (APC), a homodimerization motif, and an antigenic unit. The TLR2- and CD14-specific vaccibodies bound their respective target receptors expressed on transfected CHO cells and PBMC. Large proteins such as paired mouse Ckappa-domains (229 aa) and fragment C of tetanus toxin (TetC, 451 aa) could be expressed as antigenic units with intact serological determinants detected by mAb or polyclonal antisera. In the presence of monocytes, TLR2- and CD14-specific vaccibodies having either Ckappa or TetC as antigenic unit were 100-10,000 more efficient at stimulating T cell clones in vitro compared to non-targeted vaccibodies expressing the same antigens. The results show that TLR2 and CD14 are efficient targets for delivery of antigen to APC for stimulation of HLA class II-restricted CD4(+) T cells. Thus, receptors of innate immunity should be further explored as targets for vaccines.
Assuntos
Imunidade Inata , Imunoglobulinas/imunologia , Imunoglobulinas/metabolismo , Receptores de Lipopolissacarídeos/imunologia , Receptor 2 Toll-Like/imunologia , Vacinas Sintéticas/imunologia , Animais , Anticorpos/sangue , Anticorpos Antibacterianos/sangue , Proteínas de Bactérias/imunologia , Células CHO , Linhagem Celular , Proliferação de Células , Células Cultivadas , Cricetinae , Cricetulus , Dimerização , Ensaio de Imunoadsorção Enzimática , Humanos , Cadeias kappa de Imunoglobulina/imunologia , Imunoglobulinas/genética , Leucócitos Mononucleares , Receptores de Lipopolissacarídeos/genética , Receptores de Lipopolissacarídeos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Modelos Animais , Dados de Sequência Molecular , Ligação Proteica , Proteínas Repressoras/imunologia , Análise de Sequência de DNA , Receptor 2 Toll-Like/genética , Receptor 2 Toll-Like/metabolismo , Vacinas Sintéticas/genéticaRESUMO
BACKGROUND: The ingestion of dietary products containing sweet lupin (such as Lupinus albus or Lupinus angustifolius) has been reported to cause IgE-mediated allergic reactions. Recent studies have indicated lupin globulins as important IgE binding proteins. The aim of the present study was to generate and characterize monoclonal antibodies (mAbs) against lupin seed proteins. METHODS: Mice were immunized with a protein isolate from L. albus and mAbs were obtained by hybridoma techniques. Albumins and globulins were extracted, and the globulin fraction was separated further into conglutins by anion exchange chromatography. Specificities, binding patterns and applications of the mAbs were investigated by immunochemical methods. RESULTS: Five mAbs were produced: Lu11 (an IgG2b antibody), Lu8, Lu18, Lu34 and Lu35 (all IgM antibodies). The mAbs reacted strongly with protein isolates from both L. albus and L. angustifolius. All mAbs are directed towards the lupin globulin fraction; Lu11 and Lu18 recognize alpha-conglutin, while Lu8, Lu34 and Lu35 recognize beta-conglutin. In addition, Lu11 inhibited the binding of IgE from patients with positive skin prick tests to lupin proteins in a competitive ELISA by approximately 30%. Furthermore, preliminary results show that Lu11 can be used to develop a sensitive method for the detection of alpha-conglutin in foods. CONCLUSIONS: Lupin globulins are immunogenic and alpha-conglutin is a potential allergen. This is the first study describing mAbs against the candidate lupin allergens, emphasizing the importance of additional studies on conglutins in lupin allergy.
Assuntos
Anticorpos Monoclonais/imunologia , Proteínas de Plantas/imunologia , Animais , Anticorpos Monoclonais/biossíntese , Especificidade de Anticorpos , Ensaio de Imunoadsorção Enzimática , Feminino , Imunização , Imunoglobulina E/imunologia , Camundongos , Camundongos Endogâmicos BALB C , Proteínas de Armazenamento de SementesRESUMO
OBJECTIVE: A patient presented with heavy-chain deposition disease (HCDD), exhibiting severe erosive polyarthropathy caused by synovial deposits of abnormal monoclonal, heavily deleted free gamma3 heavy chains lacking the V(H) and C(H)1 domains. The absence of V(H) was surprising, since it is considered important for pathogenic tissue deposition. This study was undertaken to analyze the genetic structure of the heavy chain, the protein product synthesized in vitro, and that deposited in the synovium in comparison with the serum and urinary proteins. METHODS: Hybridomas were made by fusion of blood and bone marrow mononuclear cells with mouse myeloma cells. Cloned B cell hybridomas secreting gamma3 were selected and analyzed by polymerase chain reaction. Purified hybridoma Ig was sequenced by Edman degradation. Antiserum raised to a peptide corresponding to residues 2-15 of the truncated V(H) was used in Western blots of synovial tissue. RESULTS: The hybridomas secreted free gamma3 chains consisting of a V(H)4 gene truncated 21 nucleotides into the first complementarity-determining region and then reading straight into the hinge region. The amino acid sequence confirmed the presence of residues 1-32 of the V(H)4 gene. Immunoblotting of synovial tissue showed the presence of Ig with truncated V(H). CONCLUSION: The gamma3 heavy chain had a deletion of V(H) from codon 33 and of the entire C(H)1. In vivo, the 32 V(H) amino acids were proteolytically degraded. In the joint, however, the 32 residues of V(H) remained intact, consistent with a pathogenic role of V(H) for tissue deposition. To our knowledge, this is the first reported case of gammaHCDD causing an erosive, polyarticular arthropathy as the dominating clinical feature.
Assuntos
Artrite Reumatoide/genética , Deleção de Genes , Doença das Cadeias Pesadas/genética , Cadeias Pesadas de Imunoglobulinas/genética , Cadeias gama de Imunoglobulina/genética , Sequência de Aminoácidos , Artrite Reumatoide/metabolismo , Artrite Reumatoide/patologia , Sequência de Bases , Western Blotting , Células da Medula Óssea , Células Clonais , Feminino , Doença das Cadeias Pesadas/metabolismo , Doença das Cadeias Pesadas/patologia , Humanos , Hibridomas , Cadeias Pesadas de Imunoglobulinas/metabolismo , Cadeias gama de Imunoglobulina/metabolismo , Leucócitos Mononucleares , Pessoa de Meia-Idade , Dados de Sequência Molecular , RNA Mensageiro/isolamento & purificação , Membrana Sinovial/metabolismo , Membrana Sinovial/patologiaRESUMO
Here, we have investigated if targeting of T cell epitopes to chemokine receptors results in improved CD4+ T cell responses. Mouse monoclonal antibodies (mAb) with kappaL chains were targeted to various chemokine receptors expressed on human monocytes or immature dendritic cells (DC), and proliferation of cloned human, DR4-restricted CD4+ T cells specific for mouse Ckappa(40-48) was measured. When using monocytes as antigen-presenting cells, mAb specific for CCR1, CCR2, CCR5, and CXCR4 were 100-10,000-fold more efficient at inducing T cell proliferation when compared to isotype-matched control mAb on a per molecule basis. Targeting of immature DC was less effective and was only seen with anti-CCR1 and anti-CXCR4 mAb. Anti-chemokine receptors mAb required to be processed by the conventional endosomal MHC class II presentation pathway. The mAb did not induce signaling through the chemokine receptors as they failed to induce mobilization of cytosolic Ca2+ and actin polymerization. They also failed to induce APC maturation. The results strongly suggest that chemokine receptors channel antigen into the endocytic pathway for presentation on MHC class II molecules. Targeting T cell epitopes to chemokine receptors by recombinant antibody should be a useful vaccine strategy for the induction of strong CD4+ T cell responses.
Assuntos
Anticorpos/imunologia , Células Apresentadoras de Antígenos/imunologia , Antígenos/imunologia , Linfócitos T CD4-Positivos/imunologia , Receptores de Quimiocinas/imunologia , Actinas/metabolismo , Animais , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/metabolismo , Cálcio/metabolismo , Antígenos de Histocompatibilidade Classe II/imunologia , Humanos , Camundongos , Receptores CCR1 , Receptores CCR2 , Receptores CCR5/imunologia , Receptores CXCR4/imunologiaRESUMO
The percentage of CD27(+) B cells in peripheral blood (PB) of patients with primary Sjögren's syndrome (pSS) is significantly decreased compared to normals. In contrast, serum levels of the soluble form of CD27 (sCD27) are significantly higher in pSS patients, with a strong positive correlation between sCD27 and serum IgG levels. In vitro experiments demonstrate that normal B cells cultured under conditions driving plasma cell differentiation result in the production of substantial amounts of sCD27. Analyses of V(H)-region genes from sorted CD27(+) and CD27(-) B cells from pSS patients confirm that the CD27(+) population corresponds to the somatically mutated memory compartment, as in healthy individuals. Together our data indicate that in pSS, there is an abnormal differentiation of B cells to plasma cells resulting in a depression of the circulating memory B-cell pool and the release of significant amounts of sCD27 and IgG.
Assuntos
Linfócitos B/fisiologia , Imunoglobulina G/sangue , Memória Imunológica , Síndrome de Sjogren/imunologia , Adulto , Idoso , Artrite Reumatoide/imunologia , Antígenos CD40/fisiologia , Diferenciação Celular , Feminino , Humanos , Imunoglobulina A/sangue , Imunoglobulina G/classificação , Cadeias Pesadas de Imunoglobulinas/genética , Imunoglobulina M/sangue , Região Variável de Imunoglobulina/genética , Masculino , Pessoa de Meia-Idade , Membro 7 da Superfamília de Receptores de Fatores de Necrose Tumoral/biossíntese , Membro 7 da Superfamília de Receptores de Fatores de Necrose Tumoral/sangueRESUMO
In vaccine development, a major objective is to induce strong, specific T cell responses. This might be obtained by targeting antigen to cell surface molecules that efficiently channel the antigen into endocytic compartments for loading of MHC molecules. Antibodies have been used to deliver antigen; however, it is important to define optimal targets on antigen-presenting cells (APC) for efficient delivery. For this purpose, we have established a T cell readout that can be used to screen large numbers of different mAb for their ability to load MHC class II molecules. The novel human CD4+ T cell clone is specific for mouse Ig C kappa (40-48) and restricted by HLA-DR4 (DRA1,B1*0401). DR4 apparently presents both mouse and human C kappa 40-48, but there is no cross-reaction at the T cell level. B cells from DR4 transgenic mice spontaneously process and present the mouse C kappa peptide. The mouse C kappa -specific T cell readout was used to demonstrate that mouse mAb specific for human dendritic cell (DC)-specific ICAM-grabbing non-integrin (DC-SIGN), a novel DC-specific molecule, were 10- to 1000-fold more potent at inducing kappa-specific human CD4+ T cell proliferation compared to control mAb. Consistent with this finding, DC-SIGN-specific mAb were rapidly internalized upon binding and found in intracellular vesicles. These results strongly argue that DC-SIGN-specific mAb are channeled into the MHC class II presentation pathway. Thus, DC-SIGN could be an efficient target for antibody-mediated delivery of T cell epitopes in vaccine development.
Assuntos
Apresentação de Antígeno , Linfócitos T CD4-Positivos/imunologia , Moléculas de Adesão Celular/imunologia , Células Dendríticas/imunologia , Antígenos HLA-DR/imunologia , Cadeias kappa de Imunoglobulina/imunologia , Lectinas Tipo C/imunologia , Receptores de Superfície Celular/imunologia , Animais , Anticorpos Monoclonais/imunologia , Linfócitos T CD4-Positivos/citologia , Divisão Celular , Linhagem Celular , Humanos , Camundongos , Camundongos TransgênicosRESUMO
An ideal vaccine for induction of CD4(+) T cell responses should induce local inflammation, maturation of APC, and peptide loading of MHC class II molecules. Ligation of Toll-like receptor (TLR) 2 provides the first two of these three criteria. We have studied whether targeting of TLR2 results in loading of MHC class II molecules and enhancement of CD4(+) T cell responses. To dissociate MHC class II presentation from APC maturation, we have used an antagonistic, mouse anti-human TLR2 mAb (TL2.1) as ligand and measured proliferation of a mouse Ckappa-specific human CD4(+) T cell clone. TL2.1 mAb was 100-1000 times more efficiently presented by APC compared with isotype-matched control mAb. Moreover, TL2.1 mAb was internalized into endosomes and processed by the conventional MHC class II pathway. This novel function of TLR2 represents a link between innate and adaptive immunity and indicates that TLR2 could be a promising target for vaccines.
Assuntos
Apresentação de Antígeno , Antígenos/metabolismo , Vacinas Bacterianas/imunologia , Linfócitos T CD4-Positivos/imunologia , Linfócitos T CD4-Positivos/metabolismo , Endocitose/imunologia , Glicoproteínas de Membrana/metabolismo , Receptores de Superfície Celular/metabolismo , Sequência de Aminoácidos , Anticorpos Monoclonais/metabolismo , Anticorpos Monoclonais/farmacologia , Especificidade de Anticorpos , Apresentação de Antígeno/genética , Células Apresentadoras de Antígenos/citologia , Células Apresentadoras de Antígenos/imunologia , Células Apresentadoras de Antígenos/metabolismo , Antígenos/genética , Linhagem Celular , Células Clonais , Endocitose/genética , Endossomos/imunologia , Endossomos/metabolismo , Epitopos de Linfócito T/metabolismo , Humanos , Imunidade Ativa , Imunidade Inata , Regiões Constantes de Imunoglobulina/metabolismo , Cadeias kappa de Imunoglobulina/metabolismo , Ligantes , Glicoproteínas de Membrana/genética , Glicoproteínas de Membrana/imunologia , Dados de Sequência Molecular , Receptores de Superfície Celular/genética , Receptores de Superfície Celular/imunologia , Receptor 2 Toll-Like , Receptores Toll-LikeRESUMO
The interaction of CD95 with its ligand CD95L is important for negative selection of B cells during the germinal center (GC) reaction. Recently, mutations conferring resistance to CD95-induced apoptosis have been described for human GC B cells. Hence, as has been demonstrated for CD95-deficient mice, also GC-derived autoreactive B cells carrying somatic CD95 gene mutations may potentially service negative selection and participate in the development of autoimmune diseases. Here, single plasmablasts (PB) which are implicated in the production of autoantibodies in systemic lupus erythematosus (SLE) patients as well as ten human B cell lines producing autoantibodies were analyzed for destructive somatic CD95 gene mutations. However, inactivating CD95 gene mutations were very rare in PB and not detected in the cell lines. Sequence analysis of V gene rearrangements amplified from single PB confirmed that the cells are (post) GC B cells and additionally demonstrated massive clonal expansion of these cells in two of four SLE patients. We conclude that CD95 gene mutations play little if any role in the generation of the pool of PB in SLE patients and that mutations in the CD95 gene are rare among autoantibody-producing B cells in SLE and rheumatoid arthritis.